Back

Baseline hemoglobin and bleeding risk in patients with myocardial infarction treated with PCI

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Interventional Cardiology ePosters Outcome ESC Premium Access ESC Congress 2020

About the speaker

Photo
Assistant Professor Vojko Kanic

University Medical Centre Maribor, Maribor (Slovenia)

174 More presentations in this session

Presentation thumbnail
Clinical profile and predictors of positivity of acetylcholine test in patients with angina and no obstructive coronary artery disease. Results of a multi-center mediterranean registry.
Doctor L. Grigorian (Madrid, ES)
Abstract Slides
Presentation thumbnail
Comparison of neointimal coverage between biodegradable-polymer everolimus-eluting stent and durable-polymer everolimus-eluting stent using angioscopy for the patients with acute coronary syndrome
Assistant Professor T. Umemoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Global risk factors of contrast-Induced acute kidney injury: systematic review and meta-analysis
Doctor L. Liu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Post-procedural quantitative flow ratio gradient and target lesion revascularization after drug-coated balloon or plain-old balloon angioplasty
Doctor H. Kirigaya (Yokohama, JP)
Abstract Slides
Presentation thumbnail
Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pressure pullbacks gradients (PPG) index.
Doctor A. Candreva (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Interventional Cardiology ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease
thumbnail
Congress Presentation
Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources